1652.HK

Fusen Pharmaceutical Company Limited 1652.HK

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 1652.HK 1011.HK 3737.HK 0897.HK 1942.HK 1643.HK 2297.HK 1612.HK 0455.HK 2389.HK
6M 162.96 % 222.22 % -32.58 % 20.55 % 12.50 % 70.37 % 52.17 % 128.95 % -25.00 % -3.95 %
YTD -11.25 % 222.22 % -39.39 % 81.07 % -59.90 % 100.00 % 75.00 % 117.50 % -21.51 % -5.19 %
1Y -27.55 % 120.25 % -32.58 % 116.75 % -69.32 % 84.00 % 78.34 % 102.33 % -28.57 % -12.05 %
3Y -26.80 % 1 015.38 % -20.00 % 33.33 % -87.18 % 62.35 % -88.28 % 117.50 % -22.86 % -1.35 %
5Y -82.43 % -26.27 % -62.73 % 49.15 % -50.61 % -45.24 % -94.70 % -58.57 % -16.15 % -34.23 %
10Y -72.05 % -99.57 % -75.71 % -75.42 % -19.00 % -45.24 % -94.70 % -7.45 % -66.25 % -90.52 %
From the beginning -72.05 % -20.91 % -74.90 % -99.99 % -19.00 % -45.24 % -94.70 % -7.45 % -86.50 % -97.15 %

Dividend

Fusen Pharmaceutical Company Limited

China NT Pharma Group Company Limited

Zhongzhi Pharmaceutical Holdings Limited

Wai Yuen Tong Medicine Holdings Limited

MOG Holdings Limited

Modern Chinese Medicine Group Co., Ltd.

Vincent Medical Holdings Limited